| scholarly article | Q13442814 |
| P50 | author | Anne Estreicher | Q53587969 |
| P2093 | author name string | T Frebourg | |
| F Waridel | |||
| C Fontolliet | |||
| P Monnier | |||
| R Iggo | |||
| J-M Flaman | |||
| L Bron | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 163-169 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract | |
| P478 | volume | 14 |
| Q34066368 | 11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation |
| Q40910139 | Adenovirus type 5 E1A immortalizes primary rat cells expressing wild-type p53. |
| Q48309999 | Aging and the rise of somatic cancer-associated mutations in normal tissues |
| Q33738770 | Alcohol intake-associated skin and mucosal cancer |
| Q54337645 | Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma. |
| Q55476499 | Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. |
| Q33299319 | Changes in allelic imbalances in locally advanced breast cancers after chemotherapy |
| Q73169074 | Clinical importance of molecular determinations in gynecologic patients with multiple tumors |
| Q34381303 | Cutaneous field cancerization: clinical, histopathological and therapeutic aspects |
| Q81551267 | Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma |
| Q54790351 | Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast. |
| Q38104997 | Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer |
| Q74421286 | Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract |
| Q35130560 | Expression of C-terminal deleted p53 isoforms in neuroblastoma |
| Q21092375 | Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen |
| Q48154511 | Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines |
| Q44931020 | Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations |
| Q34431421 | Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes |
| Q34017847 | Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications |
| Q82578753 | Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary? |
| Q31889996 | Genetic mechanisms in squamous cell carcinoma of the head and neck |
| Q35765161 | Genetically abnormal clones in histologically normal breast tissue |
| Q52597650 | HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell. |
| Q39174622 | High frequency of temperature-sensitive mutants of p53 in glioblastoma |
| Q34949417 | Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture |
| Q28539684 | Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade |
| Q78392713 | Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer |
| Q78128596 | Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis |
| Q77648381 | Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck |
| Q73713407 | Laryngeal mucosa of head and neck cancer patients shows increased DNA damage as detected by single cell microgel electrophoresis |
| Q48300384 | Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene |
| Q47103510 | Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies |
| Q39861412 | Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma. |
| Q47869174 | Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. |
| Q33739841 | Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. |
| Q92538958 | Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes |
| Q27005678 | Multifocal epithelial tumors and field cancerization: stroma as a primary determinant |
| Q35789054 | Multiple head and neck tumors frequently originate from a single preneoplastic lesion |
| Q43913681 | Multiple primary malignant neoplasms in patients with esophageal cancer |
| Q38493190 | Oral field cancerization: an update on current concepts |
| Q37987046 | Oral field cancerization: current evidence and future perspectives |
| Q42523782 | Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. |
| Q33739357 | Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX |
| Q33248782 | Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. |
| Q26786210 | Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma |
| Q39603028 | Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy |
| Q33748119 | Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis |
| Q38349905 | SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. |
| Q35623597 | Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation |
| Q34561566 | Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions |
| Q74618492 | Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database |
| Q73318922 | Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers |
| Q85068912 | TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations |
| Q34234217 | TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial |
| Q35669976 | The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing |
| Q77421660 | The molecular genetics of head and neck cancer |
| Q47106643 | The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma. |
| Q84243511 | The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer |
| Q40567737 | ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis. |
| Q33729053 | Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions |
| Q44145277 | Validation of a yeast functional assay for p53 mutations using clonal sequencing |
| Q78008248 | [Barrett's esophagus: the biological reality of a premaligmant columnar metaplasia] |
| Q81758508 | p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients |
| Q36644176 | p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients |
| Q52540552 | p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. |
| Q61988945 | p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements |
| Q77560853 | p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma |
| Q41339413 | p53, p63 and p73 in the wonderland of S. cerevisiae |
Search more.